Commission Implementing Regulation (EU) 2024/324 [Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin (OJ L, 2024/324, 22.1.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/324/oj).] extended the approval period of the active substance fluazinam until 15 April 2026, and the approval period of the active substance fluopyram until 30 June 2026.
Recital 34, Regulation (EU) 2026/372
In forcesince 20 Feb 2026